CoLucid Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock

CONTACT
Thomas Mathers
Chief Executive Officer
CoLucid Pharmaceuticals, Inc.
(857) 285-6494 

Hans Vitzthum
Managing Director
LifeSci Advisors, LLC.
(212) 915-2568
1 2 3
View single page >> |

Disclosure: None.

How did you like this article? Let us know so we can better customize your reading experience.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.